2nd Quarter - Report
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- Issues related to the development of therapies for rare diseases. - H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; - H.R.6000, Cures 2.0 Act; - FY2022 Budget Reconciliation (H.R.5376); - H.R.5585, Advanced Research Project Agency-Health Act; - H.R.6963, Accelerated Approval Integrity Act of 2022; - H.R.7667, Food and Drug Amendments of 2022; - S.4348, FDASLA Act of 2022 - Issues relative to formulary placement of non-scheduled treatments
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATE MCCANLESS | — |
| GEOFFREY WERTH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.